Medpace
Medpace returns on capital
Annual and trailing 12-month returns on invested capital, equity and assets.
ROIC
% · Annual / TTM
ROCE
% · Annual / TTM
ROIIC
% · Annual / TTM
Reported borrowing balances are unavailable in the extracted statements for this period.
ROE
% · Annual / TTM
ROA
% · Annual / TTM
ROIC − WACC
Percentage points · Scenario
Quarterly data
| Fiscal period | Ended | ROIC% | ROCE% | ROIIC% | ROE% | ROA% | ROIC − WACCPercentage points |
|---|---|---|---|---|---|---|---|
| FY 2026 Q2 | Jun 30, 2026 | — | 119.92% | — | 162.15% | 27.09% | — |
| FY 2026 Q1 | Mar 31, 2026 | — | 72.18% | — | 77.25% | 22.87% | — |
| FY 2025 Q4 | Dec 31, 2025 | — | 65.72% | — | 70.23% | 22.13% | — |
| FY 2025 Q3 | Sep 30, 2025 | — | 67.08% | — | 73.7% | 22.57% | — |
| FY 2025 Q2 | Jun 30, 2025 | — | 74.72% | — | 89.38% | 23.96% | — |
| FY 2025 Q1 | Mar 31, 2025 | — | 56.54% | — | 65.82% | 22.55% | — |
| FY 2024 Q4 | Dec 31, 2024 | — | 51.72% | — | 58.41% | 21.52% | — |
| FY 2024 Q3 | Sep 30, 2024 | — | 48.64% | — | 54.06% | 20.48% | — |
| FY 2024 Q2 | Jun 30, 2024 | — | 51.5% | — | 58.83% | 20.43% | — |
| FY 2024 Q1 | Mar 31, 2024 | — | 52.43% | — | 61.31% | 19.58% | — |
| FY 2023 Q4 | Dec 31, 2023 | — | 52.6% | — | 59.79% | 18.8% | — |
| FY 2023 Q3 | Sep 30, 2023 | — | 56.89% | — | 66.52% | 19.41% | — |
| FY 2023 Q2 | Jun 30, 2023 | — | 64.35% | — | 79.63% | 19.74% | — |
| FY 2023 Q1 | Mar 31, 2023 | — | 47.03% | — | 53.93% | 18.76% | — |
| FY 2022 Q4 | Dec 31, 2022 | — | 33.75% | — | 36.62% | 16.29% | — |
| FY 2022 Q3 | Sep 30, 2022 | — | 32.81% | — | 36.31% | 15.61% | — |
| FY 2022 Q2 | Jun 30, 2022 | — | 32.51% | — | 36.83% | 15.03% | — |
| FY 2022 Q1 | Mar 31, 2022 | — | 24.33% | — | 27.26% | 14.3% | — |
| FY 2021 Q4 | Dec 31, 2021 | — | 19.35% | — | 20.63% | 11.92% | — |
| FY 2021 Q3 | Sep 30, 2021 | — | 19.9% | — | 21.55% | 12.72% | — |
| FY 2021 Q2 | Jun 30, 2021 | — | 20.35% | — | 22.01% | 13.04% | — |
| FY 2021 Q1 | Mar 31, 2021 | — | 19.87% | — | 20.19% | 12.34% | — |
| FY 2020 Q4 | Dec 31, 2020 | — | 19.08% | — | 18.92% | 11.48% | — |
| FY 2020 Q3 | Sep 30, 2020 | — | 17.48% | — | 16.72% | 10.5% | — |
| FY 2020 Q2 | Jun 30, 2020 | — | 16.42% | — | 15.28% | 9.54% | — |
| FY 2020 Q1 | Mar 31, 2020 | — | 17.76% | — | 16.42% | 10.28% | — |
| FY 2019 Q4 | Dec 31, 2019 | — | 16.85% | — | 15.22% | 9.52% | — |
| FY 2019 Q3 | Sep 30, 2019 | — | 16.51% | — | 14.87% | 9.24% | — |
| FY 2019 Q2 | Jun 30, 2019 | — | 16.31% | — | 14.77% | 8.94% | — |
| FY 2019 Q1 | Mar 31, 2019 | — | 14.41% | — | 13.7% | 7.86% | — |
| FY 2018 Q4 | Dec 31, 2018 | 11.71% | 13.76% | — | 13.34% | 7.63% | 4 pp |
| FY 2018 Q3 | Sep 30, 2018 | 9.92% | 11.49% | — | 11.07% | 6.5% | 2.2 pp |
| FY 2018 Q2 | Jun 30, 2018 | 8.25% | 9.86% | — | 9.08% | 5.41% | 0.6 pp |
| FY 2018 Q1 | Mar 31, 2018 | 7.14% | 8.87% | — | 7.97% | 4.66% | -0.6 pp |
| FY 2017 Q4 | Dec 31, 2017 | 6.21% | 8.27% | — | 7.01% | 4.05% | -1.5 pp |
| FY 2017 Q3 | Sep 30, 2017 | 5.45% | 7.81% | — | 4.78% | 2.89% | -2.2 pp |
| FY 2017 Q2 | Jun 30, 2017 | — | — | — | — | — | — |
| FY 2017 Q1 | Mar 31, 2017 | — | — | — | — | — | — |
| FY 2016 Q4 | Dec 31, 2016 | — | — | — | — | — | — |
| FY 2016 Q3 | Sep 30, 2016 | — | — | — | — | — | — |
Sources and calculations
Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.
Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.
Quarterly returns use trailing 12-month earnings and period-end balances averaged with the same fiscal quarter one year earlier. NOPAT uses the reported effective tax rate only when pretax profit is positive and the rate is between 0 and 100%. WACC starts at 7.7%, rounded from the US nonfinancial market · generic proxy benchmark in NYU Stern · January 2026. It is an editable US sector proxy applied across history, not a company estimate; foreign reporting currencies also need a currency-specific assessment.
Market prices: Yahoo Finance · MEDP, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.
- ROIC
- NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
- ROCE
- Operating income / average (assets − current liabilities) × 100, using period end and one year earlier.
- ROIIC
- Year-over-year change in annual/TTM NOPAT / positive year-over-year change in invested capital × 100. Capital reductions and missing inputs yield unavailable values.
- ROE
- Earnings attributable to owners / average equity attributable to owners × 100, using period end and one year earlier.
- ROA
- Net income / average total assets × 100, using period end and one year earlier.
- ROIC − WACC
- ROIC less your WACC assumption, in percentage points. The same scenario rate is applied across history; it is not a reported or historical company WACC.